Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results

DOI: 10.5500/wjt.v8.i5.178

Keywords: Chronic-active antibody-mediated rejection, Kidney transplantation, Donor-specific antibody, Rituximab

Full-Text